NCT06330155 · NOT YET RECRUITING
A Genetic Study for Alzheimer Dementia: Case-control Study
This is an observational genetic study, not a drug trial. Researchers are comparing the DNA of people who have Alzheimer's dementia against healthy adults over 60 to identify genes linked to the disease. There is no intervention or treatment involved. The phase is unspecified because this is a data-collection study, not a clinical trial testing a therapy.
Eligibility criteria
1. Inclusion Criteria: Alzheimer's dementia patient * Adult patients over 60 years old * Patients with a Alzheimer's dementia patient * Total Korean version of mini-mental state examination (K-MMSE) score less than 24 * Total Clinical Dementia Rating (CDR) over 0.5 2. Inclusion Criteria: healthy subjects * Adult healthy over 60 years old * Total Korean version of mini-mental state examination (K-MMSE) over 24 * Total Clinical Dementia Rating (CDR) is 0 3. Exclusion Criteria: * Those with severe medical conditions such as unstable conditions of the cardiovascular system, digestive system, respiratory system, endocrine system, etc., who are in poor general condition * In the case of a person with impaired consent (MMSE less than 10 points), if not accompanied by a guardian * Other cases where the researcher determines that participation in this clinical trial is not appropriate (Patients who are participating in other studies or have participated in other studies within the past 30 days can also participate in this study.)
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2024-04-04